Abstract: Antimicrobial compounds, such as silanol or alcohol, include a protecting or leaving group that can protect the compound from degradation during the process of preparing a medical device containing the compound or reduce the volatility of the compound relative to its counterpart without the leaving group. Nearly any hydrolysable leaving group may be employed. The leaving group may be an agent that may serve a therapeutic function in addition to protecting or retaining the antimicrobial agents.
Type:
Grant
Filed:
August 15, 2008
Date of Patent:
May 8, 2012
Assignee:
Medtronic, Inc.
Inventors:
Paul Hsien-Fu Wu, Catherine E. Taylor, Linnus Cheruiyot, Jianwei Li, Terese A. Bartlett, Matt Bergan
Abstract: A magnetic tunnel junction cell includes a ferromagnetic reference layer, a ferromagnetic free layer, and a non-magnetic barrier layer separating the ferromagnetic reference layer from the ferromagnetic free layer. The magnetic tunnel junction cell has an asymmetric energy barrier for switching between a high resistance data state and a low resistance data state.
Type:
Grant
Filed:
July 6, 2009
Date of Patent:
May 1, 2012
Assignee:
Seagate Technology LLC
Inventors:
Wenzhong Zhu, Xiaohua Lou, Dimitar V. Dimitrov
Abstract: An introducer apparatus with a plurality of cutting edges along the outer surface of the distal end of an introducer with a blunt distal end is disclosed. The introducer may be adapted to extend from and be withdrawn into the sheath. The cutting edges may resect tissue located around the insertion site.
Type:
Grant
Filed:
September 21, 2006
Date of Patent:
May 1, 2012
Assignee:
Mayo Foundation for Medical Education and Research
Abstract: The present invention includes cold-adapted, acid-fast bacterium for use as a vaccine and a vaccine vector. In preferred embodiments, the cold-adapted, acid-fast bacterium is a Mycobacteria, for example, Mycobacteria shottsii.
Type:
Grant
Filed:
December 8, 2006
Date of Patent:
May 1, 2012
Assignee:
University of Georgia Research Foundation, Inc.
Inventors:
Frederick Quinn, Candace McCombs, Russell K. Karls
Abstract: A switching element that includes a first semiconductor layer, the first semiconductor layer having a first portion and a second portion; a second semiconductor layer, the second semiconductor layer having a first portion and a second portion; an insulating layer disposed between the first semiconductor layer and the second semiconductor layer; a first metal contact in contact with the first portion of the first semiconductor layer forming a first junction and in contact with the first portion of the second semiconductor layer forming a second junction; a second metal contact in contact with the second portion of the first semiconductor layer forming a third junction and in contact with the second portion of the second semiconductor layer forming a fourth junction, wherein the first junction and the fourth junction are Schottky contacts, and the second junction and the third junction are ohmic contacts.
Type:
Grant
Filed:
July 13, 2009
Date of Patent:
April 17, 2012
Assignee:
Seagate Technology LLC
Inventors:
Young Pil Kim, Nurul Amin, Dadi Setiadi, Venugopalan Vaithyanathan, Wei Tian, Insik Jin
Abstract: A resistive sense memory apparatus includes a bipolar select device having a semiconductor substrate, a plurality of collector contacts disposed in a first side of the of the semiconductor substrate, an emitter contact layer disposed in a second side of the semiconductor substrate, and a base layer separating the plurality of collector contacts from the emitter contact layer. Each collector contact is electrically isolated from each other. A resistive sense memory cells is electrically coupled to each collector contacts and a bit line. The base layer and the emitter contact layer provide an electrical path for the plurality of collector contacts.
Abstract: The invention provides a process for amidating a desired peptide comprising cleaving a substrate polypeptide at a X1-cysteine sequence, wherein X1 is the amino acid at the peptide carboxyl-terminus and cysteine is the first amino acid of a palladium cleavage site comprising the sequence cysteine-X2-X3, wherein X2 is any amino acid, X3 is an amino acid selected from the group consisting of cysteine, histidine, or methionine, and wherein the carboxyl-terminus of the peptide is amidated upon cleavage at the X1-cysteine sequence.
Type:
Grant
Filed:
August 28, 2008
Date of Patent:
April 10, 2012
Assignee:
Medtronic, Inc.
Inventors:
Barton Holmquist, Daniel J. Strydom, Jin Seog Seo
Abstract: A delivery needle apparatus in which a sleeve is fitted over an exterior surface of a delivery needle and methods of manufacturing the same. An elongate medical device may be delivered through the interior of the delivery needle and out of an opening in the distal end of the delivery needle (i.e., the delivery opening). The sleeve may cover a proximal portion of the delivery opening and may align an elongate medical device during insertion and/or withdrawal through the delivery opening.
Abstract: An isolation system for use in damping and isolating low frequency oscillations and shock loads between two members. An exemplary application is a seat isolation system for use with a vehicle such as a lawn mower. The seat isolation system may include two or more isolators interposed between a chassis of the vehicle, and a seat (e.g., operator's seat). The isolators may permit attenuation of shock or low frequency oscillation inputs via damping and isolation in both vertical and horizontal (fore-and-aft and side-to-side) directions. In some embodiments, the isolators include an elastomeric element that provides the seat with six degrees of freedom.
Abstract: The present invention include a method of protecting an animal against Lawsonia intracellularis infections, the method including administering a dose of live virulent L. intracellularis to the animal, allowing a subclinical L. intracellularis infection to develop in the animal, and administering one or more antibiotics to the animal, wherein the one or more antibiotic is administered in a dose sufficient to abbreviate the subclinical L. intracellularis infection.
Abstract: Devices, systems and methods for delivering one or more drugs to one or more internal body locations (such as the cerebrospinal fluid) are disclosed. In various aspects, the systems and methods may involve catheters having infusion sections with permeable membranes that develop significant back pressure to enhance uniform delivery of the drug over an infusion section; catheters that have two or more infusion sections spaced apart along the length of the same catheter, catheters that include two or more infusion sections serviced by independent lumens (such that, e.g., different drug solutions can be delivered to the different infusion sections); implantable drug delivery systems with pumps and multiple reservoirs from which drugs can be delivered; systems that are capable of delivering drug solutions with selected densities; etc. Methods for treating diseases, including pain and spasticity are also discussed, as well as methods for screening patients and optimizing therapies.
Abstract: The present disclosure relates to methods of selectively placing a reference column or reference row in a memory array. The method includes measuring a resistance state resistance value for a plurality of variable resistive memory cells within a memory array and mapping a location of each measured variable resistive memory cell to form a map of the resistance state resistance values for a plurality of variable resistive memory cells within a memory array. Then a column or row is selected to be a reference column or reference row based on the map of the resistance state resistance value for a plurality of variable resistive memory cells within a memory array, to minimize read operation errors, and forming a variable resistive memory cell memory array.
Type:
Grant
Filed:
December 15, 2010
Date of Patent:
March 20, 2012
Assignee:
Seagate Technology LLC
Inventors:
Yiran Chen, Hai Li, Wenzhong Zhu, Xiaobin Wang, Henry Huang, Hongyue Liu
Abstract: 1,3-Dipole-functional compounds (e.g., azide functional compounds) can be reacted with certain alkynes in a cyclization reaction to form heterocyclic compounds. Useful alkynes (e.g., strained, cyclic alkynes) and methods of making such alkynes are also disclosed. The reaction of 1,3-dipole-functional compounds with alkynes can be used for a wide variety of applications including the immobilization of biomolecules on a substrate.
Type:
Grant
Filed:
November 21, 2008
Date of Patent:
March 13, 2012
Assignee:
University of Georgia Research Foundation, Inc.
Inventors:
Geert-Jan Boons, Jun Guo, Xinghai Ning, Margaretha Wolfert
Abstract: Programmable metallization memory cells having a planarized silver electrode and methods of forming the same are disclosed. The programmable metallization memory cells include a first metal contact and a second metal contact, an ion conductor solid electrolyte material is between the first metal contact and the second metal contact, and either a silver alloy doping electrode separates the ion conductor solid electrolyte material from the first metal contact or the second metal contact, or a silver doping electrode separates the ion conductor solid electrolyte material from the first metal contact. The silver electrode includes a silver layer and a metal seed layer separating the silver layer from the first metal contact.
Type:
Grant
Filed:
January 30, 2009
Date of Patent:
March 13, 2012
Assignee:
Seagate Technology LLC
Inventors:
Tian Wei, Dexin Wang, Venugopalan Vaithyanathan, Yang Dong, Muralikrishnan Balakrishnan, Ivan Petrov Ivanov, Ming Sun, Dimitar Velikov Dimitrov
Abstract: A method of manufacturing a hermetic lead connector includes fixing an electrically insulating ring between an electrically conducting contact ring and an electrically conducting spacer ring to form a hermetic ring subassembly, and fixing a plurality of the hermetic ring subassemblies in axial alignment to form a hermetic lead connector. The hermetic lead connector includes an open end, an outer surface, and an inner surface defining a lead aperture. The hermetic lead connector provides a hermetic seal between the outer surface and the inner surface.
Type:
Grant
Filed:
April 10, 2007
Date of Patent:
March 6, 2012
Assignee:
Medtronic, Inc
Inventors:
Darren A. Janzig, Gerald G. Lindner, Chris J. Paidosh
Abstract: A shielded integrated circuit structure including an integrated circuit having a plurality of functional elements thereon, and a tiled array comprising a plurality of shielding elements, each functional element having one of the plurality of shielding elements proximate thereto. The shielding elements comprise a magnetic material having a saturation less than or equal to 20,000 gauss.
Abstract: Methods using phosphatidylserine, lysophosphatidylserine, and/or salts thereof to increase testosterone levels in subjects in need thereof are disclosed herein. The methods can be useful for subjects having age related decline in testosterone, exercise induced decline in testosterone, and/or hypogonadism.
Type:
Grant
Filed:
November 30, 2008
Date of Patent:
February 28, 2012
Assignee:
Chemi Nutra, LLC
Inventors:
Martin Purpura, Ralf Jäger, Scott L. Hagerman
Abstract: A tunneling magneto-resistive reader includes a sensor stack separating a top magnetic shield from a bottom magnetic shield. The sensor stack includes a reference magnetic element having a reference magnetization orientation direction and a free magnetic element having a free magnetization orientation direction substantially perpendicular to the reference magnetization orientation direction. A non-magnetic spacer layer separates the reference magnetic element from the free magnetic element. A first side magnetic shield and a second side magnetic shield is disposed between the top magnetic shield from a bottom magnetic shield, and the sensor stack is between the first side magnetic shield and the second side magnetic shield. The first side magnetic shield and the second side magnetic shield electrically insulates the top magnetic shield from a bottom magnetic shield.
Type:
Grant
Filed:
July 13, 2009
Date of Patent:
February 28, 2012
Assignee:
Seagate Technology LLC
Inventors:
Dimitar V. Dimitrov, Zheng Gao, Wonjoon Jung, Paul Edward Anderson, Olle Gunnar Heinonen
Abstract: Programmable metallization memory cells having a first metal contact and a second metal contact with an ion conductor solid electrolyte material between the metal contacts. The first metal contact has a filament placement structure thereon extending into the ion conductor material. In some embodiments, the second metal contact also has a filament placement structure thereon extending into the ion conductor material toward the first filament placement structure. The filament placement structure may have a height of at least about 2 nm.
Type:
Grant
Filed:
January 27, 2011
Date of Patent:
February 28, 2012
Assignee:
Seagate Technology LLC
Inventors:
Insik Jin, Christina Hutchinson, Richard Larson, Lance Stover, Jaewoo Nam, Andrew Habermas